Akèy › Pemfigis › Pennsylvania
Etid klinik pou Pemfigis nan Pennsylvania
3 etid pou Pemfigis ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jul 22, 2026 · NCT06371417A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT04422912Autoimmune Blistering Diseases Study
- Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Department of Dermatology, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT02753777Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.